| Phase 01 trial |
|
Phase 0
|
NCT01239875 |
Nov 2010 → Nov 2015 |
MALT lymphoma, Waldenstrom macroglobulinemia, chronic lymphocytic leukemia/small lymphocytic lymphoma, grade III lymphomatoid granulomatosis +6 |
Mayo Clinic |
Completed
|
No outcome recorded
|
| Phase 1/22 trials · 1 met primary |
|
Phase 1/2
|
NCT00499577 |
Dec 2006 → Feb 2009 |
plasma cell myeloma |
University of Maryland Greenebaum Cancer Center |
Completed
|
Met primary
|
|
Phase 1/2
|
NCT00046852 |
Dec 2001 → Nov 2004 |
infectious disease, plasma cell myeloma |
University of Maryland, Baltimore |
Completed
|
No outcome recorded
|
| Phase 24 trials |
|
Phase 2
|
NCT05417165 |
Sep 2023 → Oct 2026 expected |
chronic lymphocytic leukemia/small lymphocytic lymphoma |
Seema Bhat |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05183854 |
Jan 2022 → Mar 2027 expected |
chronic lymphocytic leukemia/small lymphocytic lymphoma |
University of Utah |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT01351896 |
Nov 2011 → Jul 2024 overdue |
pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma |
National Cancer Institute (NCI) |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT00445484 |
Jan 2007 → Apr 2009 |
plasma cell myeloma |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Completed
|
No outcome recorded
|